Health

The investigative reporting on cancer patients being denied care at Memorial Medical Center in Las Cruces, New Mexico sheds light on the disturbing trend of for-profit entities taking over nonprofit hospitals. This represents a significant ethical issue within the healthcare system, as patients like Barbara Quarrell are being turned away due to insurance complications. The
Rep. Jamie Raskin’s statement regarding Dr. Anthony Fauci sheds light on the importance of distinguishing fact from fiction in the ongoing investigation into the origins of COVID-19. By acknowledging that Fauci is not a comic book super-villain, Raskin challenges the simplistic narratives that often dominate public discourse. Dr. Jason Liebowitz’s experience with a physician-owned practice
The SYNERGY-NASH phase II study conducted by Rohit Loomba, MD, provided promising results regarding the resolution of metabolic dysfunction-associated steatohepatitis (MASH) and liver fibrosis. Among the 190 participants with biopsy-confirmed MASH and fibrosis, the treatment regimen showed resolution of MASH without worsening of fibrosis in significant percentages across different dosages of tirzepatide as compared to
The use of transvenous phrenic nerve stimulation (TPNS) has been found to greatly improve clinical outcomes for patients suffering from central sleep apnea and heart failure. A win ratio analysis conducted during the Remedē system pivotal trial showed a significant advantage for the treatment group compared to the control group, with a five-fold higher chance
A groundbreaking study has shed light on the potential benefits of a triplet combination involving brentuximab vedotin (BV) for patients with diffuse large B-cell lymphoma (DLBCL). The study demonstrated that this combination therapy, consisting of BV, lenalidomide, and rituximab, led to significant improvements in overall survival (OS) compared to lenalidomide-rituximab alone in the third-line setting.
Chronic inflammatory demyelinating polyneuropathy (CIDP) is a challenging disease to diagnose and treat due to its rarity and heterogeneity. Current standard treatments like intravenous immunoglobulin (IVIG), steroids, and plasma exchange are not always effective, especially in certain CIDP phenotypes. This has prompted the search for valid biomarkers that can aid in both the diagnosis and